A Self-controlled Trial of Prophylactic Topical Application of Vitamin K1 Cream for Cetuximab-related Skin Rash -VANQUISH trial-
Ontology highlight
ABSTRACT: Interventions: Vitamin K1 cream
Plcebo cream
Primary outcome(s): The incidence of grade2-5 rash acneiform (CTCAE v4.0) of face whithin 4 weeks from starting cetuximab containing chemotherapy
Study Design: Parallel Randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2625669 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA